Close Menu

Molecular Devices

The deal covers use within the life sciences, food and beverage research, and environmental testing markets.

NEW YORK (GenomeWeb News) – Molecular Devices today announced a global distribution agreement with Fluxion Biosciences covering its IonFlux instruments and consumables.
Molecular Devices also is providing support for all IonFlux Systems users as part of the deal, it said.

In Brief This Week is a Friday column containing news items that our readers may have missed during the week.

In Brief This Week is a Friday column containing news items that our readers may have missed during the week.

New Product Watch: Jun 14, 2011

Premium

Affymetrix's Human Genome U133+ PM Array Strip, Molecular Devices' GenePix SL50 Slide Loader and GenePix Pro 7.2 Software

Molecular Devices will distribute the software to customers in the research and pharmaceutical markets worldwide.

Molecular Devices will also sell ChanTest's cell optimization services to Molecular Devices' customers worldwide using its PatchXpress 7000A, IonWorks Quattro, IonWorks Barracuda, and FLIPR Tetra systems.

Movers & Shakers: Jul 23, 2010

Premium

Didier Hirsch, Riaz Bandali

The acquisitions of AB Sciex and Molecular Devices helped Danaher's Medical Technologies segment increase its revenues 31 percent during the quarter.

The EPO has upheld Molecular Devices' patent cover patch-clamp technology, but the firm that opposed the patent said that it has been amended.

Pages

23andMe has a holiday popup shop at a mall and could open additional stores, Bloomberg reports.

By studying koalas and a retrovirus that infects them, researchers may have uncovered a new sort of 'immune response' that occurs at the genomic level, Agence France Presse reports.

NPR reports that the first person in the US given a gene editing-based therapy for a genetic disorder is heading home.

In Science this week: ancient genomes reveal social inequality within individual households, new method for quantifying genetic variation in gene dosage, and more.